Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report

BACKGROUND: Multiple sclerosis (MS) is considered an autoimmune disease of the central nervous system and therapeutic inhibition of leukocyte migration with natalizumab, an anti-alpha4 integrin antibody, is highly effective in patients with MS. Recent studies performed in experimental animal models...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotgiu, Stefano, Murrighile, Maria R, Constantin, Gabriela
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954970/
https://www.ncbi.nlm.nih.gov/pubmed/20863362
http://dx.doi.org/10.1186/1471-2377-10-84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954970/
https://www.ncbi.nlm.nih.gov/pubmed/20863362
http://dx.doi.org/10.1186/1471-2377-10-84

Ejemplares similares